PHARMACOKINETICS OF SIMEPREVIR (TMC435) IN VOLUNTEERS WITH MODERATE OR SEVERE HEPATIC IMPAIRMENT

被引：13
|
作者：
Ouwerkerk-Mahadevan, S. [1 ]
Simion, A. [2 ]
Spittaels, K. [2 ]
Beumont-Mauviel, M. [2 ]
机构：
[1] Janssen Res & Dev, Beerse, Belgium
[2] Janssen Infect Dis BVBA, Beerse, Belgium
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60889-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
887
引用
下载
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [21] The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment
    Topletz-Erickson, Ariel R. R.
    Lee, Anthony J. J.
    Mayor, JoAl G. G.
    Sun, Hao
    Abdulrasool, Layth I.
    Rustia, Evelyn L. L.
    Walker, Luke N. N.
    Endres, Christopher J. J.
    CLINICAL PHARMACOKINETICS, 2022, 61 (12) : 1761 - 1770
  • [22] Once-Daily Simeprevir (TMC435) With Pegylated Interferon and Ribavirin in Treatment-Naive Genotype 1 Hepatitis C: The Randomized PILLAR Study
    Fried, Michael W.
    Buti, Maria
    Dore, Gregory J.
    Flisiak, Robert
    Ferenci, Peter
    Jacobson, Ira
    Marcellin, Patrick
    Manns, Michael
    Nikitin, Igor
    Poordad, Fred
    Sherman, Morris
    Zeuzem, Stefan
    Scott, Jane
    Gilles, Leen
    Lenz, Oliver
    Peeters, Monika
    Sekar, Vanitha
    De Smedt, Goedele
    Beumont-Mauviel, Maria
    HEPATOLOGY, 2013, 58 (06) : 1918 - 1929
  • [23] The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment
    De Wolf, AM
    Fragen, RJ
    Avram, MJ
    Fitzgerald, PC
    Rahimi-Danesh, F
    ANESTHESIA AND ANALGESIA, 2001, 93 (05): : 1205 - 1209
  • [24] Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment
    Chevalier, Clemence
    Dubourg, Julie
    Bolze, Sebastien
    Fouqueray, Pascale
    CLINICAL PHARMACOKINETICS, 2021, 60 (04) : 485 - 490
  • [25] Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment
    Clémence Chevalier
    Julie Dubourg
    Sébastien Bolze
    Pascale Fouqueray
    Clinical Pharmacokinetics, 2021, 60 : 485 - 490
  • [26] Pharmacokinetics of Maribavir in Subjects with Moderate Hepatic Impairment
    Song, I. H.
    Ilic, K.
    Wu, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 792 - 792
  • [27] Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment
    Grasela, DM
    Christofalo, B
    Kollia, GD
    Duncan, G
    Noveck, R
    Manning, JA
    LaCreta, FP
    PHARMACOTHERAPY, 2000, 20 (06): : 87S - 94S
  • [28] Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients
    Reesink, Henk W.
    Fanning, Gregory C.
    Abou Farha, Khalid
    Weegink, Christine
    Van Vliet, Andre
    van 't Klooster, Gerben
    Lenz, Oliver
    Aharchi, Fatima
    Marien, Kris
    Van Remoortere, Pieter
    de Kock, Herman
    Broeckaert, Fabrice
    Meyvisch, Paul
    Van Beirendonck, Els
    Simmen, Kenneth
    Verloes, Rene
    GASTROENTEROLOGY, 2010, 138 (03) : 913 - 921
  • [29] PHARMACOKINETICS OF FLUPIRTINE IN ELDERLY VOLUNTEERS AND IN PATIENTS WITH MODERATE RENAL IMPAIRMENT
    ABRAMS, SML
    BAKER, LRI
    CROME, P
    WHITE, AST
    JOHNSTON, A
    ANKIER, SI
    WARRINGTON, SJ
    TURNER, P
    NIEBCH, G
    POSTGRADUATE MEDICAL JOURNAL, 1988, 64 (751) : 361 - 363
  • [30] Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1-infected patients in Japan: the DRAGON study
    Hayashi, Norio
    Seto, Chiharu
    Kato, Mai
    Komada, Yuji
    Goto, Shoichiro
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (01) : 138 - 147
12345